You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moderate to Severe Atopic Dermatitis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Moderate to Severe Atopic Dermatitis Trial (SHR-1819 injection)

Not yet recruiting
  • Moderate to Severe Atopic Dermatitis
  • SHR-1819 injection
  • (no location specified)
Aug 22, 2023

Atopic Dermatitis Trial (CM310)

Not yet recruiting
  • Atopic Dermatitis
  • CM310
  • (no location specified)
Oct 30, 2023

Atopic Dermatitis, Eczema Trial (Lebrikizumab)

Not yet recruiting
  • Atopic Dermatitis
  • Eczema
  • Lebrikizumab
  • (no location specified)
Aug 7, 2023

Canadian Patients Receiving Dupixent® for Moderate to Severe

Recruiting
  • Moderate to Severe Atopic Dermatitis
    • Toronto, Ontario, Canada
    • +1 more
    Oct 24, 2023

    Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

    Not yet recruiting
    • Atopic Dermatitis
    • Baricitinib 4 MG
    • Azathioprine 1.5-2.5 mg/kg
    • Sari, Mazandaran, Iran, Islamic Republic of
      Iran
    Aug 1, 2023

    Atopic Dermatitis Trial (BxC-I17e, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • (no location specified)
    Sep 20, 2023

    Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • SAR444656 (KT-474)
    • Placebo
    • (no location specified)
    Sep 21, 2023

    Dermatitis, Atopic Trial (GSK1070806, Placebo)

    Not yet recruiting
    • Dermatitis, Atopic
    • (no location specified)
    Aug 22, 2023

    Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Atopic Dermatitis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Jianzhong Zhang
    Oct 10, 2023

    Moderate-to-severe Atopic Dermatitis Trial in Beijing (CM326, Placebo)

    Recruiting
    • Moderate-to-severe Atopic Dermatitis
    • CM326
    • Placebo
    • Beijing, Beijing, China
      Peking University People's hospital
    Feb 21, 2022

    Moderate to Severe Atopic Dermatitis Trial in Nanjing (VC005 tablets, VC005 Tablets Placebo)

    Recruiting
    • Moderate to Severe Atopic Dermatitis
    • VC005 tablets
    • VC005 Tablets Placebo
    • Nanjing, Jiangsu, China
      Chinese Academy of Medical Sciences Hospital for Skin Diseases
    Aug 16, 2023

    Medical Care of Moderate-to-severe Atopic Dermatitis -

    Recruiting
    • Atopic Dermatitis
      • Bern, Switzerland
        Inselspital, Department of Dermatology
      Apr 17, 2023

      Moderate-to-severe Atopic Dermatitis Trial in Beijing (CM326, Placebo)

      Recruiting
      • Moderate-to-severe Atopic Dermatitis
      • CM326
      • Placebo
      • Beijing, China
        Peking University People's hospital
      Dec 31, 2022

      Dermatitis, Atopic Trial in Germany

      Recruiting
      • Dermatitis, Atopic
        • Bramsche, Germany
        • +7 more
        May 23, 2022

        Atopic Dermatitis Trial in North Little Rock, Camp Hill, Philadelphia (BxC-I17e, Placebo)

        Recruiting
        • Atopic Dermatitis
        • North Little Rock, Arkansas
        • +2 more
        Sep 20, 2023

        Atopic Dermatitis Trial (CM310)

        Not yet recruiting
        • Atopic Dermatitis
        • CM310
        • (no location specified)
        Jan 27, 2023

        Atopic Dermatitis Trial in Roma (Upadacitinib)

        Recruiting
        • Atopic Dermatitis
        • Upadacitinib
        • Roma, Italy
          Irccs Fondazione Policlinico Gemelli
        Aug 4, 2023

        Atopic Dermatitis Trial (LEO 138559, Placebo)

        Not yet recruiting
        • Atopic Dermatitis
        • LEO 138559
        • Placebo
        • (no location specified)
        Jun 20, 2023

        Learn About Abrocitinib in Adult Moderate to Severe Atopic

        Not yet recruiting
        • Atopic Dermatitis
        • Eczema
        • (no location specified)
        Jan 9, 2023

        Atopic Dermatitis Trial in Shanghai (MG-K10/Placebo)

        Active, not recruiting
        • Atopic Dermatitis
        • MG-K10/Placebo
        • Shanghai, China
          Huashan Hospital Affiliated to Fudan University
        Aug 31, 2023

        Dermatitis Atopic Trial (Amlitelimab)

        Not yet recruiting
        • Dermatitis Atopic
        • (no location specified)
        Mar 3, 2023

        Atopic Dermatitis Trial (Caffeine, Metoprolol, Midazolam)

        Not yet recruiting
        • Atopic Dermatitis
        • Caffeine
        • +6 more
        • (no location specified)
        May 26, 2023

        Atopic Dermatitis Trial in Beijing (Jaktinib Hydrochloride Tablet)

        Recruiting
        • Atopic Dermatitis
        • Jaktinib Hydrochloride Tablet
        • Beijing, Beijing, China
          11 Xizhimen South Street
        Jan 6, 2023

        Atopic Dermatitis, Eczema Trial (Lebrikizumab, Placebo)

        Not yet recruiting
        • Atopic Dermatitis
        • Eczema
        • (no location specified)
        Feb 10, 2023